| Literature DB >> 18438736 |
Masaaki Tamura1, Heping Yan, Ofelia Zegarra-Moro, Jennifer Edl, Stephanie Oursler, Cindy Chard-Bergstrom, Gordon Andrews, Tsutomu Kanehira, Susumu Takekoshi, Ray Mernaugh.
Abstract
To gain insight into the mechanism by which angiotensin II type 2 receptor (AT(2)) regulates carcinogen-induced lung tumorigenesis, we have newly developed anti-AT(2) single chain variable fragment (ScFv) antibodies using a rodent phage-displayed recombinant antibody library with various peptide fragments of the receptor protein, and investigated the expression of the AT(2) receptor protein. The specificity of the antibodies was verified using AT(2) over-expressing COS-7 cells and AT(2) naturally expressing PC12W cells. In control wild type mouse lung, a stronger immunoreactivity was observed in bronchial epithelial cells. A moderate immunoreactivity was detected in pulmonary vascular walls and vascular endothelial cells. In the lungs possessing tobacco-specific nitrosamine (NNK)-induced tumors, significantly increased AT(2) and AT(1 )immunostaining was observed in adenomatous lesions. These data suggest that the increase in both receptors' expression in the alveolar epithelial cells may be accompanied with the onset of NNK-induced tumorigenesis and hence play important roles in lung tumorigenesis.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18438736 PMCID: PMC2914475 DOI: 10.1007/s10735-008-9172-3
Source DB: PubMed Journal: J Mol Histol ISSN: 1567-2379 Impact factor: 2.611